RZLT
#2990
Rezolute, Inc. - Common Stock
4.6 4 USD
-0.07%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.83%
Variación mensual
-5.88%
Variación en los últimos 6 meses
+53.14%
Cambio anual
-36.35%
Cierres anteriores
4.9 8
Open
4.6 0
Mínimo
4.5 8
Máximo
4.6 4
Volumen
641
Financials
- Market Capitalization 446.8 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.55
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2984 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.21 USD | -4.55% | -1.34% | +5.34% | -10.14% | 451.35 M USD | ||
| 2989 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.97 USD | -4.13% | -4.26% | -9.48% | -21.51% | 448.45 M USD | ||
| 3002 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | -4.76% | 0.00% | +18.23% | -31.03% | 432.21 M USD | ||
| 3021 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 12.27 USD | +4.25% | +8.68% | +21.97% | +36.94% | 430.27 M USD |